Review Of The Drug Enforcement Administration's (DEA) Control Of The Diversion Of Controlled Pharmaceuticals
- NARA ID
- review-drug-enforcement-administrations-dea-control-diversion-controlled-pharmaceuticals
- Source
- oig-doj
- Collection
- DOJ OIG — Other
- Agency
- U.S. DOJ Office of the Inspector General
- Classification
- Inspection / Evaluation
- Released
- 2002-09-01
- Slug
- doj-oig-review-drug-enforcement-administrations-dea-control-diversion-controlled-pharmaceuticals
- Indexed
- 2026-04-27 05:13:58
More from DOJ OIG — Other
- Denver Police Department, Crime Laboratory Bureau, Denver, Colorado
- University of Arizona
- National Association of Drug Court Professionals
- No Suspect Casework DNA Backlog Reduction Program, Cooperative Agreement Awarded to the State of Texas, Department of Public Safety, Austin, Texas
- Review of Department of Justice Data Quality Procedures for Recovery Act Recipient Reports, October 2009
- Report to Congress on Implementation of Section 1001 of the USA PATRIOT Act
About the DOJ OIG — Other collection
U.S. DOJ Office of the Inspector General reports (audits, investigations, evaluations, and reviews) concerning this DOJ component.